Narang, Ankita
Lacaze, Paul
Ronaldson, Kathlyn J. http://orcid.org/0000-0003-4728-009X
McNeil, John J. http://orcid.org/0000-0002-1049-5129
Jayaram, Mahesh http://orcid.org/0000-0002-5352-1075
Thomas, Naveen
Sellmer, Rory
Crockford, David N.
Stowe, Robert
Greenway, Steven C.
Pantelis, Christos http://orcid.org/0000-0002-9565-0238
Bousman, Chad A. http://orcid.org/0000-0001-6303-8696
Funding for this research was provided by:
National Heart Foundation of Australia (102604)
Article History
Received: 13 July 2021
Revised: 8 February 2022
Accepted: 14 February 2022
First Online: 23 April 2022
Competing interests
: CAB is the founder and a shareholder of Sequence2Script Inc and a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and Pharmacogene Variation Consortium (PharmVar). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.